Article Text
Statistics from Altmetric.com
Inhaled methoxyflurane has been used in the civilian prehospital setting to treat pain for several decades.1 Despite having attributes that are well suited to the deployed environment,2 its introduction to military settings appears to be more recent and, to our knowledge, there is only one published study in this setting.3 We aimed to explore the experience of clinicians administering methoxyflurane via the Penthrox inhalator device (Galen, UK), following its introduction to the UK Defence Medical Services (DMS) in 2021.
Between 22 May 2022 and 3 March 2023, DMS clinicians were invited to complete a survey using a web-based form. The survey was distributed electronically and advertised at educational events. Of a total of 48 reported administration events, most (69%) were provided by doctors with the remainder delivered by other military healthcare providers. All …
Footnotes
X @maxmarsden83
Correction notice Thia articles has been corrected since it first published. Affiliations for Stuart McPhail have been changed from 1) Academic Department of Military Anaesthesia, RCI, UK Defence Medical Services, Birmingham, UK to 1) Department of Anaesthesia, Torbay Hospital, Devon, UK, 2) Department of Health and Community Sciences, University of Exeter, Exeter, UK.
Contributors AK, SM, DO and AT conceived the study. SM, AT and DO developed and carried out the study and initial data analysis. MERM completed subsequent analysis. SM drafted the manuscript. All authors commented on, and contributed to, the final draft. AK acts as the guarantor for this work.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.